ARTIFICIAL INTELLIGENCE AS A DECISION TOOL FOR SKIN LESIONS TRIAGE IN PRIMARY CARE: A NARRATIVE REVIEW
Authors:
- Zuzanna PietrukZPZuzanna Pietruk
- Michał KozickiMKMichał Kozicki
- Przemysław SiemiątkowskiPSPrzemysław Siemiątkowski
- Agnieszka KiedikAKAgnieszka Kiedik
- Sylwia SkraińskaSSSylwia Skraińska
- Julia KozłowskaJKJulia Kozłowska
- Jakub Chamier-GliszczyńskiJCJakub Chamier-Gliszczyński
- Dominik Ryszard PłazaDPDominik Ryszard Płaza
- Kacper ZimaKZKacper Zima
Open Access
- 14 March 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
Abstract
Background: Skin lesions are one of the common reasons for consultations in primary care (PC). Among them, skin cancers are a key clinical challenge, where early detection is crucial for the patient’s prognosis. Primary care physicians (PCPs) are responsible for the initial classification of skin conditions, determining which cases require referral to a specialist. In recent years, solutions using artificial intelligence (AI) have been gaining growing interest in medicine, offering new possibilities for diagnostic support, including in the field of dermatology. Objectives: The aim of this narrative review is to analyze the literature on whether and how artificial intelligence (AI) can support primary care physicians in the initial classification of skin lesions. Methods: A comprehensive review of the literature regarding the application of artificial intelligence in skin cancer diagnosis was conducted. The analysis covered results from clinical trials and reviews identifying implementation barriers. Key findings: Results from recent multicenter clinical trials demonstrate that Artificial Intelligence algorithms achieve high diagnostic sensitivity for melanoma, as well as robust accuracy for non-melanoma skin cancers. Comparative studies indicate that while AI performance is comparable to that of board-certified dermatologists, it statistically outperforms less experienced physicians. Conclusion: The conclusions from the study indicate that artificial intelligence can support primary care physicians by increasing their diagnostic effectiveness in the triage of skin lesions. As a support tool, it has the potential to reduce the risk of missing cancers while reducing the number of unreasonable referrals to specialists. However, a key condition for introducing these technologies into everyday clinical practice is to resolve identified ethical and technological barriers.Keywords
This publication has 14 references indexed in Scilit:
- Evaluation of an artificial intelligence-based decision support for the detection of cutaneous melanoma in primary care: a prospective real-life clinical trialBritish Journal of Dermatology, 2024
- Comparison of humans versus mobile phone-powered artificial intelligence for the diagnosis and management of pigmented skin cancer in secondary care: a multicentre, prospective, diagnostic, clinical trialThe Lancet Digital Health, 2023
- Artificial Intelligence in Dermatology: Challenges and PerspectivesDermatology and Therapy, 2022
- Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040JAMA Dermatology, 2022
- The global burden of skin cancer: A longitudinal analysis from the Global Burden of Disease Study, 1990–2017JAAD International, 2021
- Artificial intelligence-based image classification methods for diagnosis of skin cancer: Challenges and opportunitiesComputers in Biology and Medicine, 2020
- Algorithm based smartphone apps to assess risk of skin cancer in adults: systematic review of diagnostic accuracy studiesBMJ, 2020
- Dermoscopy for melanoma detection and triage in primary care: a systematic reviewBMJ Open, 2019
- Automated Classification of Skin Lesions: From Pixels to PracticeJournal of Investigative Dermatology, 2018
- Dermatologist-level classification of skin cancer with deep neural networksNature, 2017